Shanghai Pharmaceuticals Unveils Three New Products with Canadian Regulatory Approvals

Stock News07-30

Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH) announced that three of its products, manufactured by its subsidiary Shanghai Zhonghua Pharmaceutical Co., Ltd., have received product licenses from Natural and Non-prescription Health Products Directorate (NNHPD) of Health Canada. The approved products include Longhu Qingliangyou Regular, Longhu Qingliangyou Ultra, and Longhu Gunzhu Fengyoujing Oil.

These three products are primarily indicated for the temporary relief of muscle and joint aches or discomfort. Shanghai Zhonghua Pharmaceutical Co., Ltd. submitted the product registration application to Natural and Non-prescription Health Products Directorate (NNHPD) of Health Canada in May 2026. As of the date of this announcement, the company has incurred registration costs of approximately RMB 49,500 for the marketing of these products in Canada.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1151892383?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-30 16:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151892383","market":"sh","top_or_hot":-1,"title":"Shanghai Pharmaceuticals Unveils Three New Products with Canadian Regulatory Approvals","media":"Stock News","content":"<p><b>Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH)</b> announced that three of its products, manufactured by its subsidiary <b>Shanghai Zhonghua Pharmaceutical Co., Ltd.</b>, have received product licenses from <b>Natural and Non-prescription Health Products Directorate (NNHPD)</b> of Health Canada. The approved products include <b>Longhu Qingliangyou Regular</b>, <b>Longhu Qingliangyou Ultra</b>, and <b>Longhu Gunzhu Fengyoujing Oil</b>.<br><br>These three products are primarily indicated for the temporary relief of muscle and joint aches or discomfort. <b>Shanghai Zhonghua Pharmaceutical Co., Ltd.</b> submitted the product registration application to <b>Natural and Non-prescription Health Products Directorate (NNHPD)</b> of Health Canada in May 2026. As of the date of this announcement, the company has incurred registration costs of approximately RMB 49,500 for the marketing of these products in Canada.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Pharmaceuticals Unveils Three New Products with Canadian Regulatory Approvals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Pharmaceuticals Unveils Three New Products with Canadian Regulatory Approvals\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-30 16:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH)</b> announced that three of its products, manufactured by its subsidiary <b>Shanghai Zhonghua Pharmaceutical Co., Ltd.</b>, have received product licenses from <b>Natural and Non-prescription Health Products Directorate (NNHPD)</b> of Health Canada. The approved products include <b>Longhu Qingliangyou Regular</b>, <b>Longhu Qingliangyou Ultra</b>, and <b>Longhu Gunzhu Fengyoujing Oil</b>.<br><br>These three products are primarily indicated for the temporary relief of muscle and joint aches or discomfort. <b>Shanghai Zhonghua Pharmaceutical Co., Ltd.</b> submitted the product registration application to <b>Natural and Non-prescription Health Products Directorate (NNHPD)</b> of Health Canada in May 2026. As of the date of this announcement, the company has incurred registration costs of approximately RMB 49,500 for the marketing of these products in Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0209","symbol_name":"零售","start_time":0,"source_url":"","article_id":"1151892383","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151892383","pubTimestamp":1785398427,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH) announced that three of its products, manufactured by its subsidiary Shanghai Zhonghua Pharmaceutical Co., Ltd., have received product licenses...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601607":"上海医药","BK0209":"零售","BK0183":"MSCI概念","BK0097":"医药电商","BK0188":"融资融券","BK0099":"上海本地重组","BK0012":"证金概念","BK0196":"行业龙头","BK0175":"白马股","BK0187":"一线龙头","BK0184":"上海国资改革","02607":"上海医药","BK0028":"国家队","BK1197":"保健护理产品经销商","BK0020":"浦东新区"},"translate_title":"上海医药推出三款获得加拿大监管批准的新产品","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1,"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH) announced that three of its products, manufactured by its subsidiary Shanghai Zhonghua Pharmaceutical Co., Ltd., have received product licenses from Natural and Non-prescription Health Products Directorate (NNHPD) of Health Canada. The approved products include Longhu Qingliangyou Regular, Longhu Qingliangyou Ultra, and Longhu Gunzhu Fengyoujing Oil.These three products are primarily indicated for the temporary relief of muscle and joint aches or discomfort. Shanghai Zhonghua Pharmaceutical Co., Ltd. submitted the product registration application to Natural and Non-prescription Health Products Directorate (NNHPD) of Health Canada in May 2026. As of the date of this announcement, the company has incurred registration costs of approximately RMB 49,500 for the marketing of these products in Canada.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1151892383","isCrawlerRequest":true}